Use of pumpkin seed (Cucurbita pepo) versus placebo and versus alpha-blockers in the management of benign prostatic hyperplasia: a systematic review and meta-analysis of randomized controlled trials
Acta Cirúrgica Brasileira · 2026 · 41
DOI: 10.1590/acb416626 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Acta Cirúrgica Brasileira, 2026. Verfasst von Bianca Caroline Benedicto und 10 weiteren Autor:innen. Beteiligte Einrichtung: Universidade Nove de Julho - School of Medicine - Urology Department - São Bernardo do Campo (SP) - Brazil. Hauptthemen laut MEDLINE: Cucurbita, Prostatic Hyperplasia, Seeds, Adrenergic alpha-Antagonists. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
To compare pumpkin seed (Cucurbita pepo) with placebo and, separately, with alpha-blockers in men with benign prostatic hyperplasia-related lower urinary tract symptoms.
Methods
Five databases were searched to 30 April 2025 for randomized controlled trials (RCTs). The primary outcome was change in international prostate symptom score (IPSS), and secondary outcomes included maximum urinary flow (Qmax), prostate volume, prostate-specific antigen (PSA) and adverse events. Each comparator was analyzed separately by random-effects meta-analysis, with RoB 2 for risk of bias.
Results
Eight RCTs (2,170 men) were included. Versus placebo, pumpkin seed reduced IPSS at three months (mean difference -0.62, 95% confidence interval [95%CI] -1.15 to -0.09) but not at six months; versus alpha-blockers there was no difference (1.91, IC95% -0.24–4.07). Qmax improved versus placebo only; no other outcome differed from alpha-blockers. Adverse events were fewer with pumpkin seed in one head-to-head trial (odds ratio = 0.21, IC95% 0.07–0.63).
Conclusion
Pumpkin seed offers at most a small sub-clinical IPSS benefit over placebo, not maintained at six months, and no significant difference from alpha-blockers. Certainty was low to very low; equivalence is not established.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Universidade Nove de Julho - School of Medicine - Urology Department - São Bernardo do Campo (SP) - Brazil.
- Hapvida NotreDame - Research Department - São Paulo (SP) - Brazil.
- Universidade Federal de São Paulo - Escola Paulista de Medicina - Urology Department - São Paulo (SP) - Brazil.
Zitieren
APA
Benedicto, B. C., Constantinou, B. T., Leite Junior, A. M., Orra, S. H., Molina, B. S., Almeida, T. P. L., Navas, B. B. D. S., Sardenberg, R. A. D. S., Almeida, F. G., Maia, R. S., & Cruz, J. A. S. D. (2026). Use of pumpkin seed (Cucurbita pepo) versus placebo and versus alpha-blockers in the management of benign prostatic hyperplasia: a systematic review and meta-analysis of randomized controlled trials. Acta Cirúrgica Brasileira, 41. https://doi.org/10.1590/acb416626
Vancouver
Benedicto BC, Constantinou BT, Leite Junior AM, Orra SH, Molina BS, Almeida TPL, et al. Use of pumpkin seed (Cucurbita pepo) versus placebo and versus alpha-blockers in the management of benign prostatic hyperplasia: a systematic review and meta-analysis of randomized controlled trials. Acta Cirúrgica Brasileira. 2026;41. doi:10.1590/acb416626
BibTeX
@article{Benedicto2026,
author = {Benedicto, Bianca Caroline and Constantinou, Beatriz Taveira and Leite Junior, Amauri Moreira and Orra, Soraya Hussein and Molina, Beatriz Sanches and Almeida, Tayná Pereira Leite de and Navas, Beatriz Brandão da Silva and Sardenberg, Rodrigo Afonso da Silva and Almeida, Fernando Gonçalves de and Maia, Ronaldo Soares and Cruz, José Arnaldo Shiomi da},
title = {Use of pumpkin seed (Cucurbita pepo) versus placebo and versus alpha-blockers in the management of benign prostatic hyperplasia: a systematic review and meta-analysis of randomized controlled trials},
journal = {Acta Cirúrgica Brasileira},
year = {2026},
volume = {41},
doi = {10.1590/acb416626}
}
EUVIMED